The crystal structure of human CDK7 and its protein recognition properties

Structure

Volumn 12, Issue 11, 2004, Pages 2067-2079

  Lolli, Graziano ^a   Lowe, Edward D ^a   Brown, Nick R ^a   Johnson, Louise N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 7; CYCLINE; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR;

ARTICLE; CRYSTAL STRUCTURE; ENZYME ACTIVITY; EUKARYOTIC CELL; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; CYCLIN-DEPENDENT KINASES; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID;

EUKARYOTA;

EID: 7944231428     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2004.08.013     Document Type: Article

References (72)

1. Akoulitchev S., Reinberg D. The molecular mechanism of mitotic inhibition of TFIIH is mediated by phosphorylation of CDK7. Genes Dev. 12:1998;3541-3550
2. Akoulitchev S., Chuikov S., Reinberg D. TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature. 407:2000;102-106
3. Bax B., Carter P.S., Lewis C., Guy A.R., Bridges A., Tanner R., Pettman G., Mannix C., Culbert A.A., Brown M.J., et al. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATide, that inhibits beta-catenin phosphorylation. Structure. 9:2001;1143-1152
4. Beattie J.F., Breault G.A., Ellston R.P., Green S., Jewsbury P.J., Midgley C.J., Naven R.T., Minshull C.A., Pauptit R.A., Tucker J.A., Pease J.E. Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 1. identification and optimisation of substituted 4,6-bis anilino pyrimidines Bioorg. Med. Chem. Lett. 13:2003;2955-2960
5. Breault G.A., Ellston R.P., Green S., James S.R., Jewsbury P.J., Midgley C.J., Pauptit R.A., Minshull C.A., Tucker J.A., Pease J.E. Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2. identification and optimisation of substituted 2,4-bis anilino pyrimidines Bioorg. Med. Chem. Lett. 13:2003;2961-2966
6. Brotherton D.H., Dhanaraj V., Wick S., Brizuela L., Domaille P., Volyanik E., Xu X., Parisini E., Smith B.O., Archer S.J., et al. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d. Nature. 395:1998;244-250
7. Brown N.R., Noble M.E.M., Endicott J.A., Johnson L.N. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat. Cell Biol. 1:1999;438-443. a
8. Brown N.R., Noble M.E.M., Lawrie A.M., Morris M.C., Tunnah P., Divita G., Johnson L.N., Endicott J.A. Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity. J. Biol. Chem. 274:1999;8746-8756. b
9. Busso D., Keriel A., Sandrock B., Poterszman A., Gileadi O., Egly J.-M. Distinct regions of MAT1 regulate cdk7 kinase and TFIIH transcrition activities. J. Biol. Chem. 275:2000;22815-22823
10. CCP4 The (Collaborative Computational Project Number 4) CCP4 suite. programs for protein crystallography Acta Crystallogr. D Biol. Crystallogr. 50:1994;760-763
11. Chang C.I., Xu B.E., Akella R., Cobb M.H., Goldsmith E.J. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol. Cell. 9:2002;1241-1249
12. Chen J., Larochelle S., Li X., Suter B. Xpd/Ercc2 regulates CAK activity and mitotic progression. Nature. 424:2003;228-232
13. Cheng A., Kaldis P., Solomon M.J. Dephosphorylation of human cyclin-dependent kinases by protein phosphatase type 2Cα and β2 isoforms. J. Biol. Chem. 275:2000;34744-34749
14. Cheng K.-Y., Lowe E.D., Sinclair J., Nigg E.A., Johnson L.N. The crystal structure of the human polo-like kinase polo-box domain and its complex with a phosphopeptide. EMBO J. 22:2003;5757-5768
15. Dahmus M.E. Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem. 271:1996;19009-19012
16. Dajani R., Fraser E., Roe S.M., Yeo M., Good V.M., Thompson V., Dale T.C., Pearl L.H. Structural basis for recruitment of glycogen synthase kinase 3 beta to the axin-APC scaffold complex. EMBO J. 22:2003;494-501
17. Davies T.G., Bentley J., Arris C.E., Boyle F.T., Curtin N.J., Endicott J.A., Gibson A.E., Golding B.T., Griffin R.J., Hardcastle I.R., et al. Structure-based design of a potent purine-based cyclin dependent kinase inhibitor. Nat. Struct. Biol. 9:2002;745-749
18. Davis S.T., Benson B.G., Bramson H.N., Chapman D.E., Dickerson S.H., Dold K.M., Eberwein D.J., Edelstein M., Frye S.V., Gampe R.T. Jr., et al. Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science. 291:2001;134-137
19. De Bondt H.L., Rosenblatt J., Jancarik J., Jones H.D., Morgan D.O., Kim S.-H. Crystal structure of cyclin dependent kinase 2. Nature. 363:1993;592-602
20. Devault A., Martinez A.-M., Fesquet D., Labbé J.-C., Morin N., Tassan J.-P., Nigg E.A., Cavadore J.-C., Dorée M. MAT1 (menage a trois) a new RING finger protein subunit stabilising cyclin H-CDK7 complexes in starfish and xenopus CAK. EMBO J. 14:1995;5027-5036
21. Elia A.E., Rellos P., Haire L.F., Chao J.W., Ivins F.J., Hoepker K., Mohammad D., Cantley L.C., Smerdon S.J., Yaffe M.B. The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell. 115:2003;83-95
22. Fabbro D., Ruetz S., Buchdunger E., Cowan-Jacob S.W., Fendrich G., Liebetanz J., Mestan J., O'Reilly T., Traxler P., Chaudhuri B., et al. Protein kinases as targets for anticancer agents. from inhibitors to useful drugs Pharmacol. Ther. 93:2002;79-98
23. Feaver W.J., Svejstrup J.Q., Henry N.L., Kornberg R.D. Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell. 79:1994;1103-1109
24. Fisher R.P., Morgan D.O. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell. 78:1994;713-724
25. Fisher R.P., Jin P., Chamberlin H.M., Morgan D.O. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell. 83:1995;47-57
26. Goodrich J.A., Tjian R. Transcription factors IIE and IIH and ATP hydrolysis direct promoter clearance by RNA polymerase II. Cell. 77:1994;145-156
27. Gray N.S., Wodicka L., Thunnissen A.M., Norman T.C., Kwon S., Espinoza F.H., Morgan D.O., Barnes G., LeClerc S., Meijer L., et al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science. 281:1998;533-538
28. Harper J.W., Elledge S.J. The role of Cdk7 in CAK function, a retro-retrospective. Genes Dev. 12:1998;285-289
29. Hanlon N., Barford D. Purification and crystallisation of the CDK-associated protein phosphatase, KAP expressed in Escherichia coli. Protein Sci. 7:1998;508-511
30. Honma T., Hayashi K., Aoyama T., Hashimoto N., Machida T., Fukasawa K., Iwama T., Ikeura C., Ikuta M., Suzuki-Takahashi I., et al. Structure-based generation of a new class of potent Cdk4 inhibitors. new de novo design strategy and library design J. Med. Chem. 44:2001;4615-4627. a
31. Honma T., Yoshizumi T., Hashimoto N., Hayashi K., Kawanishi N., Fukasawa K., Takaki T., Ikeura C., Ikuta M., Suzuki-Takahashi I., et al. A novel approach for the development of selective Cdk4 inhibitors. library design based on locations of Cdk4 specific amino acid residues J. Med. Chem. 44:2001;4628-4640. b
32. Ikuta M., Kamata K., Fukasawa K., Honma T., Machida T., Hirai H., Suzuki-Takahashi I., Hayama T., Nishimura S. Crystallographic approach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein. J. Biol. Chem. 276:2001;27548-27554
33. Jeffrey P.D., Russo A.A., Polyak K., Gibbs E., Hurwitz J., Massague J., Pavletich N.P. Mechanism of CDK activation revealed by the structure of a cyclin A-CDK2 complex. Nature. 376:1995;313-320
34. Jeffrey P.D., Tong L., Pavletich N. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev. 14:2001;3115-3125
35. Johnson L.N., Noble M.E.M., Owen D.J. Active and inactive protein kinases. Cell. 85:1996;149-158
36. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard M. Improved method for building models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:1991;110-119
37. Kaldis P., Russo A.A., Chou H.S., Pavletich N.P., Solomon M.J. Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities. Mol. Cell. Biol. 9:1998;2545-2560
38. Kwek K.Y., Murphy S., Furger A., Thomas B., O'Gorman W., Kimura H., Proudfoot N.J., Akoulitchev A. U1 snRNA associates with TFIIH and regulates transcriptional initiation. Nat. Struct. Biol. 9:2002;800-805
39. Larochelle S., Pandur J., Fisher R.P., Salz H.K., Suter B. Cdk7 is essential for mitosis and for in vivo Cdk-activating kinase activity. Genes Dev. 12:1998;370-381
40. Larochelle S., Chen J., Knights R., Pandur J., Morcillo P., Erdjument-Bromage H., Tempst P., Suter B., Fisher R.P. T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex in vivo and regulates its CTD kinase activity. EMBO J. 20:2001;3749-3759
41. Leslie, A.G.W. (1992). MOSFLM. In Joint CCP4 and ESF-EACMB Newsletter on Protein Crystallography (Warrington, U.K.: Daresbury Laboratory).
42. Lowe E.D., Tews I., Cheng K.Y., Brown N.R., Gul S., Noble M.E., Gamblin S.J., Johnson L.N. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. Biochemistry. 41:2002;15625-15634
43. Lu H., Zawel L., Fisher L., Egly J.M., Reinberg D. Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature. 358:1992;641-645
44. Martinez A.-M., Afshar M., Martin F., Cavadore J.-C., Labbé J.-C., Dorée M. Dual phosphorylation of the T-loop in CDK7. its role in controlling cyclin H binding and CAK activity EMBO J. 16:1997;343-354
45. Murshudov G.N., Vagen A.A., Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D. 53:1997;240-255
46. Nishiwaki E., Turner S.L., Harju S., Miyazaki S., Kashiwagi M., Koh J., Serizawa H. Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation. Mol. Cell. Biol. 20:2000;7726-7734
47. Noble M.E., Endicott J.A., Johnson L.N. Protein kinase inhibitors. insights into drug design from structure Science. 303:2004;1800-1805
48. Oelgeschlager T. Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control. J. Cell. Physiol. 190:2002;160-169
49. Ohkawa K., Ishida H., Nakanishi F., Hosui A., Ueda K., Takehara T., Hori M., Hayashi N. Hepatitis C virus core functions as a suppressor of cyclin-dependent kinase-activating kinase and impairs cell cycle progression. J. Biol. Chem. 279:2004;11719-11726
50. Palancade B., Bensaude O. Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation. Eur. J. Biochem. 270:2003;3859-3870
51. Poon R.Y.C., Hunter T. Dephosphorylation of Cdk2 Thr160 by the cyclin dependent kinase-interacting phosphatase KAP in the absence of cyclin. Science. 270:1995;90-93
52. Mo15. J. Cell Sci. 107:1994;2789-2799
53. Rosales J., Han B., Lee K.Y. Cdk7 functions as a cdk5 activating kinase in brain. Cell. Physiol. Biochem. 13:2003;285-296
54. Roy R., Adamczewski J.P., Seroz T., Vermuelen W., Tassan J.P., Schaeffer L., Nigg E.A., Hoeijmakers J.H., Egly J.M. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell. 79:1994;1093-1101
55. Russo A., Jeffrey P.D., Pavletich N.P. Structural basis of cyclin dependent kinase activation by phosphorylation. Nat. Struct. Biol. 3:1996;696-700. a
56. Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-CDK2 complex. Nature. 382:1996;325-331. b
57. Russo A.A., Tong L., Lee J.O., Jeffrey P.D., Pavletich N.P. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature. 395:1998;237-243
58. Schiekhattar R., Mermelstein F., Fisher R.P., Drapkin R., Dynlacht B., Wessling H.C., Morgan D.O., Reinberg D. CDK-activating kinase complex is a component of human transcription factor TFIIH. Nature. 374:1995;283-287
59. Schulze-Gahmen U., Kim S.H. Structural basis for CDK6 activation by a viral-encoded cyclin. Nat. Struct. Biol. 9:2002;177-181
60. Serizawa H. Cyclin-dependent kinase inhibitor p16INK4A inhibits phosphorylation of RNA polymerase II by general transcription factor TFIIH. J. Biol. Chem. 273:1998;5427-5430
61. Serizawa H., Makela T.P., Conaway J.W., Conaway R.C., Weinberg R.A., Young R.A. Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature. 374:1995;280-282
62. Sharrocks A.D., Yang S.H., Galanis A. Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem. Sci. 25:2000;448-453
63. Shilatifard A., Conaway R.C., Conaway J.W. The RNA polymerase II elongation complex. Annu. Rev. Biochem. 72:2003;693-715
64. Solomon M.J., Lee T., Kirschner M.W. The role of phosphorylation in p34cdc2 activation. identification of an activating kinase Mol. Biol. Cell. 3:1992;13-17
65. Song H., Hanlan N., Brown N.R., Noble M.E.M., Johnson L.N., Barford D. Phospho-protein/protein interactions. the crystal structure of Kinase Associated Phosphatase (KAP) in complex with CDK2 Mol. Cell. 7:2001;615-626
66. Soni R., O'Reilly T., Furet P., Muller L., Stephan C., Zumstein-Mecker S., Fretz H., Fabbro D., Chaudhuri B. Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4. J. Natl. Cancer Inst. 93:2001;436-446
67. Tarricone C., Dhavan R., Peng J., Areces L.B., Tsai L.H., Musacchio A. Structure and regulation of the CDK5-p25 (nck5a) complex. Mol. Cell. 8:2001;657-669
68. Tassan J., Schultz S.J., Bartek J., Nigg E.A. Cell cycle analysis of the activity, subcellular localisation, and subunit composition of human CAK. J. Cell Biol. 127:1994;467-478
69. Tassan J.-P., Jaquenoud M., Fry A.M., Frutger S., Hughes G.J., Nigg E.A. In vitro assembly of a functional human CDK7-cyclin H complex requires MAT1, a novel 36 kDa RING finger protein. EMBO J. 14:1995;5608-5617
70. Wallenfang M.R., Seydoux G. cdk-7 Is required for mRNA transcription and cell cycle progression in Caenorhabditis elegans embryos. Proc. Natl. Acad. Sci. USA. 99:2002;5527-5532
71. Watanabe Y., Fujimoto H., Watanabe T., Maekawa T., Masutani C., Hanaoka F., Ohkuma Y. Modulation of TFIIH-associated kinase activity by complex formation and its relationship with CTD phosphorylation of RNA polymerase II. Genes Cells. 5:2000;407-423
72. Yankulov K.Y., Bentley D. Regulation of CDK7 substrate specificity by MAT1. EMBO J. 16:1997;1638-1646